Evidence map›Paper›PMID 36890347›Full record

ArticleNature metabolism2023

Towards a Rosetta stone for metabolomics: recommendations to overcome inconsistent metabolite nomenclature.

Ville Koistinen, Olli Kärkkäinen, Pekka Keski-Rahkonen, Hiroshi Tsugawa, Augustin Scalbert, Masanori Arita, David Wishart, Kati Hanhineva

Abstract read
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Network-based integration of metabolomics data from large-scale repositories.Metabolomics : Official journal of the Metabolomic Society · 2026
    Article
  2. Metabolite names and identifiers: how far are we from interoperability?Metabolomics : Official journal of the Metabolomic Society · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Validation of biomarkers of aging.Nature medicine · 2024
    Review
  11. Challenges and perspectives for naming lipids in the context of lipidomics.Metabolomics : Official journal of the Metabolomic Society · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ville KoistinenFood Sciences Unit, Department of Life Technologies, University of Turku, Turku, Finland. ville.koistinen@utu.fi.ORCID http://orcid.org/0000-0003-1587-8361
Olli KärkkäinenSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0003-0825-4956
Pekka Keski-RahkonenInternational Agency for Research on Cancer, Lyon, France.
Hiroshi TsugawaTokyo University of Agriculture and Technology, Tokyo, Japan.ORCID http://orcid.org/0000-0002-2015-3958
Augustin ScalbertInternational Agency for Research on Cancer, Lyon, France.
Masanori AritaNational Institute of Genetics, Mishima, Japan.ORCID http://orcid.org/0000-0001-6706-0487
David WishartUniversity of Alberta, Edmonton, Alberta, Canada.ORCID http://orcid.org/0000-0002-3207-2434
Kati HanhinevaFood Sciences Unit, Department of Life Technologies, University of Turku, Turku, Finland.ORCID http://orcid.org/0000-0001-6834-7375

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Metabolomics

Identifiers

PMID36890347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.